|
MAGOH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.462100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.915200E-03 |
| Normal-vs-Stage2 |
5.968200E-01 |
| Normal-vs-Stage3 |
1.408760E-01 |
| Normal-vs-Stage4 |
5.078300E-02 |
| Stage1-vs-Stage2 |
2.092800E-01 |
| Stage1-vs-Stage3 |
7.739000E-01 |
| Stage1-vs-Stage4 |
3.243200E-01 |
| Stage2-vs-Stage3 |
4.070000E-01 |
| Stage2-vs-Stage4 |
7.850200E-02 |
| Stage3-vs-Stage4 |
3.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.015600E-03 |
| Normal-vs-AfricanAmerican |
3.085500E-02 |
| Normal-vs-Asian |
8.764300E-02 |
| Caucasian-vs-AfricanAmerican |
6.334000E-01 |
| Caucasian-vs-Asian |
1.517590E-01 |
| AfricanAmerican-vs-Asian |
9.647700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.263600E-03 |
| Normal-vs-Female |
4.196800E-03 |
| Male-vs-Female |
2.657600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.255200E-03 |
| Normal-vs-Extreme_Weight |
1.039270E-03 |
| Normal-vs-Obese |
9.860200E-02 |
| Normal-vs-Extreme_Obese |
5.905600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.572600E-01 |
| Normal_Weight-vs-Obese |
5.918100E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.721010E-01 |
| Extreme_Weight-vs-Obese |
9.891900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.094600E-01 |
| Obese-vs-Extreme_Obese |
6.512000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.100200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.964800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.242310E-02 |
| Normal-vs-Age(81-100Yrs) |
4.551000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.857200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.768970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.685800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.756600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.425200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.087800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.14180000000553E-05 |
| Normal-VS-Type2 PRCC |
6.639600E-01 |
| Normal-VS-KIRP CIMP |
3.752600E-01 |
| Normal-VS-Unclassified PRCC |
5.748600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.572900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.225400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.480000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
5.728200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.005600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.127600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.108400E-01 |
| Normal-vs-N1 |
1.324280E-02 |
| Normal-vs-N2 |
7.106000E-01 |
| N0-vs-N1 |
7.261900E-02 |
| N0-vs-N2 |
8.763200E-01 |
| N1-vs-N2 |
6.865400E-01 |
|
|
